UnitedHealth Stock Skyrockets 39% in Six Months Amid Easing Reimbursement Concerns

UnitedHealth Group Incorporated (UNH) stock has seen significant gains over the past six months, rising by 38.8% to outpace its industry and the S&P 500.

This improvement in performance can be attributed to several factors, including a decrease in medical costs and an easing of reimbursement concerns for Medicare Advantage payments.

UnitedHealth's medical care ratio has dropped from 87.1% to 85.3%, with medical costs decreasing by 2% to $148.8 billion in the first half of 2026.

The company is also shifting its focus towards more profitable businesses, reducing exposure to weaker-return markets and redirecting capital toward areas with better return potential.